Call for Expression of Interest for health care product developers – SEED (Shaping European Early Dialogues)
SEED – the Shaping European Early Dialogues Consortium – led by the French Haute Autorité de Santé and financed by a European Commission call for
Renewed version of the HTA Core Model® available
We are happy to present a renewed version of the HTA Core Model® – Version 2.0! What has changed? Version 2.0 is a major upgrade
Read more Press Release: EMA and EUnetHTA agree on joint 3-year work plan
Today, EMA and EUnetHTA publish a joint 3-year work plan. EUnetHTA-EMA press release
EUnetHTA strengthens its position as the scientific and technical cooperation on HTA in Europe
The first meeting of the HTA network of national authorities or bodies responsible for health technology assessment took place on October 16, 2013. The first
EUnetHTA Conference: October 30-31 2014, Rome Italy
The EUnetHTA Conference “HTA 2.0 – Teaming up for Value” will take place October 30-31, 2014 in Rome, Italy. The programme and registration details will
EUnetHTA submits Position to EMA Public Consultation
EUnetHTA has submitted a position as a response to the public consultation on the EMA draft policy on the publication and access to clinical trial
Co-chair function in the EUnetHTA Stakeholder Forum
The EUnetHTA Executive Committee and Stakeholder Forum have agreed to introduce a co-chair function to strengthen engagement of the four stakeholder groups represented in the
Concept paper on Osteoarthritis available
The concept paper on Osteoarthritis “EunetHTA guideline on data requirements for the assessment of health technologies used for the treatment of osteoarthritis of the hip
JA1 Final Technical Report available
The Final technical report on the implementation of the EUnetHTA JA1 (2010-2012) is now available. The report provides the details on the activities undertaken, results
Pilot of Rapid Assessment on ‘Zostavax for the prevention herpes zoster’ available
The first pilot of rapid assessment of WP5 JA2 Strand A on ‘Zostavax for the prevention herpes zoster’ is now available. We are pleased to